Our Blog​

Latest News

When Good Intentions Meet Bad Data: Why Pharma Patient Research Projects Go Off Track

Pharmaceutical companies invest billions to understand patients. Market research teams conduct thousands of surveys and collect patient-reported outcomes with the genuine intent of developing better therapies and launching products that...

Clinakos, Rare Disease, Integrated Patient Data, Medically Smart AI, Patient Registry, , Insights, Market Research, RWD, FDA

Why the FDA’s New Plausible Mechanism Pathway Demands a Data Revolution

FDA’s proposed Plausible Mechanism Pathway for bespoke therapies implicitly assumes a robust real‑world data (RWD) and real‑world evidence (RWE) ecosystem 1, even though the article only briefly names it in...

Clinakos, Rare Disease, Integrated Patient Data, Medically Smart AI, Patient Registry, Fraud, Insights, Market Research

Fraud in Life Sciences Market Research: A Growing Problem with a Recently Available Solution

Fraud in Life Sciences Market Research: A Growing Problem with a Recently Available Solution Market research in life sciences increasingly relies on online surveys to gather insights on patient behaviors,...

Clinakos, Rare Disease, Integrated Patient Data, Medically Smart AI, Patient Registry

The Three Pillars of High-Impact AI in Rare Diseases & Oncology

For rare diseases and oncology, where data is scarce and patients are hard to find, the margin for error is razor-thin. We believe achieving success with AI requires a strategic...